APP and Alzheimer disease: The implication of microglia in AD progression has been nicely demonstrated in the APP/PS1 AD transgenic mouse model where Aβ-mediated activation of microglial Nlrp3 inflammasome results in cognitive deficits and AD-like pathologies5.